SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Centene Corp – ‘8-K’ for 2/18/20

On:  Friday, 2/21/20, at 5:08pm ET   ·   For:  2/18/20   ·   Accession #:  1071739-20-65   ·   File #:  1-31826

Previous ‘8-K’:  ‘8-K’ on / for 2/13/20   ·   Next:  ‘8-K/A’ on 2/26/20 for 1/23/20   ·   Latest:  ‘8-K’ on / for 4/26/24   ·   9 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/21/20  Centene Corp                      8-K:8       2/18/20   12:175K

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     27K 
10: R1          Cover                                               HTML     47K 
 7: XML         IDEA XML File -- Filing Summary                      XML     11K 
 9: XML         XBRL Instance -- form8-k_htm                         XML     15K 
12: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.CAL  XBRL Calculations -- cnc-20200221_cal                XML      6K 
 4: EX-101.DEF  XBRL Definitions -- cnc-20200221_def                 XML      8K 
 5: EX-101.LAB  XBRL Labels -- cnc-20200221_lab                      XML     66K 
 6: EX-101.PRE  XBRL Presentations -- cnc-20200221_pre               XML     35K 
 2: EX-101.SCH  XBRL Schema -- cnc-20200221                          XSD     16K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    18K 
 8: ZIP         XBRL Zipped Folder -- 0001071739-20-000065-xbrl      Zip     13K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C:   C: 
  Document  
 i false i 0001071739 0001071739 2020-02-18 2020-02-18




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM  i 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):  i February 18, 2020

 i CENTENE CORPORATION
(Exact Name of Registrant as Specified in Charter)

 i Delaware
 
 
 i 42-1406317
(State or Other Jurisdiction
of Incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)
 i 7700 Forsyth Boulevard,
 
 
 i St. Louis,
 i Missouri
 
 i 63105
(Address of Principal Executive Offices)
 
(Zip Code)
Registrant’s telephone number, including area code: ( i 314)  i 725-4477
(Former Name or Former Address, if Changed Since Last Report): N/A
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 i Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company  i 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
 i Common stock, $0.001 Par Value
 
 i CNC
 
 i NYSE






ITEM 8.01 OTHER EVENTS

Kenneth Burdick, Executive Vice President of Markets and Products of Centene Corporation ("Centene" or the "Company") and former Chief Executive Officer of WellCare Health Plans, Inc. (“WellCare”), and Centene negotiated a two year employment agreement whereby Mr. Burdick would support the Company during the WellCare integration. In recent discussions with Mr. Burdick, the Company has agreed to a one year term, provided that Mr. Burdick make himself available to consult for the Company for one year subsequent to his retirement on February 21, 2021.
Mr. Burdick, in preparation for his planned retirement, entered into a 10b5-1 trading plan on February 18, 2020 to monetize a portion of his shares of Centene common stock. Rule 10b5-1 allows officers and directors, at a time when they are not in possession of material nonpublic information, to adopt written plans to sell shares on a regular basis under pre-arranged terms, regardless of any subsequent nonpublic information they may receive. Importantly, Mr. Burdick is selling only a portion of his shares pursuant to this plan and is expected to maintain significant ownership at his retirement.

Sales of common stock by Mr. Burdick pursuant to the terms of the plan, or otherwise, will be disclosed publicly through Form 144, if applicable and any required Form 4 filings with the U.S. Securities and Exchange Commission.








SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
CENTENE CORPORATION
 
 
 
 
 
Date:
By:
 
 
 
 
 
Executive Vice President & Chief Financial Officer





Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
2/21/21
Filed on:2/21/204
For Period end:2/18/2010-K
 List all Filings 


9 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/04/22  Centene Corp.                     424B5                  1:510K                                   Broadridge Fin’l So… Inc
 7/30/21  Centene Corp.                     424B5                  1:1.4M                                   Broadridge Fin’l So… Inc
 7/29/21  Centene Corp.                     424B5                  1:1.4M                                   Broadridge Fin’l So… Inc
 6/25/21  Centene Corp.                     424B5                  1:1.2M                                   Broadridge Fin’l So… Inc
 6/24/21  Centene Corp.                     424B5                  1:1.2M                                   Broadridge Fin’l So… Inc
 2/11/21  Centene Corp.                     424B5                  1:1.5M                                   Broadridge Fin’l So… Inc
 2/10/21  Centene Corp.                     424B5                  1:1.5M                                   Broadridge Fin’l So… Inc
 9/24/20  Centene Corp.                     424B5                  1:1.1M                                   Broadridge Fin’l So… Inc
 9/23/20  Centene Corp.                     424B5                  1:1.1M                                   Broadridge Fin’l So… Inc
Top
Filing Submission 0001071739-20-000065   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 8:32:07.3pm ET